Kwality [KPL] vs Gujarat Themis [GUJTHEM] Detailed Stock Comparison

Kwality Pharmaceuticals Ltd.

BSE
Loading...

Gujarat Themis Biosyn Ltd.

NSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Kwality Pharmaceuticals Ltd. wins in 10 metrics, Gujarat Themis Biosyn Ltd. wins in 9 metrics, with 0 ties. Kwality Pharmaceuticals Ltd. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Kwality Pharmaceuticals Ltd. Gujarat Themis Biosyn Ltd. Better
P/E Ratio (TTM) 30.86 73.73 Kwality Pharmaceuticals Ltd.
Price-to-Book Ratio 6.02 13.36 Kwality Pharmaceuticals Ltd.
Debt-to-Equity Ratio 38.29 27.04 Gujarat Themis Biosyn Ltd.
PEG Ratio 0.35 -17.55 Kwality Pharmaceuticals Ltd.
EV/EBITDA 17.28 52.76 Kwality Pharmaceuticals Ltd.
Profit Margin (TTM) 12.25% 29.99% Gujarat Themis Biosyn Ltd.
Operating Margin (TTM) 20.79% 40.16% Gujarat Themis Biosyn Ltd.
EBITDA Margin (TTM) 20.79% 40.16% Gujarat Themis Biosyn Ltd.
Return on Equity 15.19% 19.64% Gujarat Themis Biosyn Ltd.
Return on Assets (TTM) 8.91% 16.19% Gujarat Themis Biosyn Ltd.
Free Cash Flow (TTM) $277.15M $-251.22M Kwality Pharmaceuticals Ltd.
Dividend Yield N/A 0.17% N/A
1-Year Return 159.49% 31.69% Kwality Pharmaceuticals Ltd.
Price-to-Sales Ratio (TTM) 3.78 22.23 Kwality Pharmaceuticals Ltd.
Enterprise Value $18.21B $36.09B Gujarat Themis Biosyn Ltd.
EV/Revenue Ratio 3.95 22.65 Kwality Pharmaceuticals Ltd.
Gross Profit Margin (TTM) 52.12% 83.29% Gujarat Themis Biosyn Ltd.
Revenue per Share (TTM) $444 $15 Kwality Pharmaceuticals Ltd.
Earnings per Share (Diluted) $54.54 $4.40 Kwality Pharmaceuticals Ltd.
Beta (Stock Volatility) 0.13 -0.17 Gujarat Themis Biosyn Ltd.

Kwality Pharmaceuticals Ltd. vs Gujarat Themis Biosyn Ltd. Stock Performance Analysis

Loading Price Chart...

KPL
GUJTHEM

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Kwality Pharmaceuticals Ltd.2.22%6.00%38.44%51.48%148.86%103.68%
Gujarat Themis Biosyn Ltd.1.72%7.42%6.10%33.40%-1.19%-10.34%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Kwality Pharmaceuticals Ltd.159.49%686.37%2,110.86%10,168.22%10,168.22%10,168.22%
Gujarat Themis Biosyn Ltd.31.69%84.69%84.69%84.69%84.69%84.69%

Performance & Financial Health Analysis: Kwality Pharmaceuticals Ltd. vs Gujarat Themis Biosyn Ltd.

MetricKPLGUJTHEM
Market Information
Market Cap i₹17.47B₹35.41B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i28,89779,452
90 Day Avg. Volume i30,328106,446
Last Close₹2,344.90₹401.80
52 Week Range₹828.80 - ₹2,389.70₹225.05 - ₹479.00
% from 52W High-1.87%-16.12%
All-Time High₹2,389.70 (Jun 01, 2026)₹479.00 (Oct 27, 2025)
% from All-Time High-1.87%-16.12%
Growth Metrics
Quarterly Revenue Growth0.46%0.10%
Quarterly Earnings Growth0.88%-0.04%
Financial Health
Profit Margin (TTM) i0.12%0.30%
Operating Margin (TTM) i0.21%0.40%
Return on Equity (TTM) i0.15%0.20%
Debt to Equity (MRQ) i38.2927.04
Cash & Liquidity
Book Value per Share (MRQ)₹279.50₹24.29
Cash per Share (MRQ)₹32.82₹0.92
Operating Cash Flow (TTM) i₹387.34M₹970.68M
Levered Free Cash Flow (TTM) i₹398.45M₹487.72M
Dividends
Last 12-Month Dividend Yield iN/A0.17%
Last 12-Month Dividend i₹0.00₹0.67

Valuation & Enterprise Metrics Analysis: Kwality Pharmaceuticals Ltd. vs Gujarat Themis Biosyn Ltd.

MetricKPL (Apr 24, 2026)GUJTHEM (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i30.8673.73
Forward P/E iN/AN/A
PEG Ratio i0.35-17.55
Price to Sales (TTM) i3.7822.23
Price to Book (MRQ) i6.0213.36
Market Capitalization
Market Capitalization i₹17.47B₹35.41B
Enterprise Value i₹18.21B₹36.09B
Enterprise Value Metrics
Enterprise to Revenue i3.9522.65
Enterprise to EBITDA i17.2852.76
Risk & Other Metrics
Beta i0.13-0.17
Book Value per Share (MRQ) i₹279.50₹24.29

Financial Statements Comparison: Kwality Pharmaceuticals Ltd. vs Gujarat Themis Biosyn Ltd.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricKPL (2025)GUJTHEM (2025)
Revenue/Sales i3.70B1.51B
Cost of Goods Sold i1.87B318.78M
COGS % of Revenue i50.6%21.1%
Gross Profit i1.83B1.19B
Gross Margin i49.4%78.9%
Research & Development iN/A34.37M
Operating Income (EBIT) i620.98M642.49M
Operating Margin i16.8%42.6%
EBITDA i822.79M713.04M
EBITDA Margin i22.2%47.3%
Pre-Tax Income i541.40M655.38M
Pre-Tax Income % of Revenue i14.6%43.5%
Income Tax i143.37M167.66M
Income Tax % of Revenue i3.9%11.1%
Net Income (Profit) i398.03M487.72M
Profit Margin i10.8%32.3%

Balance Sheet & Liquidity Metrics

MetricKPL (2025)GUJTHEM (2025)
Cash & Equivalents i120.20M116.94M
Total Current Assets i2.84B519.73M
Total Current Assets % of Revenue i76.7%34.5%
Total Current Liabilities i1.70B205.60M
Total Current Liabilities % of Revenue i45.8%13.6%
Long-Term Debt i151.19M296.36M
Long-Term Debt % of Revenue i4.1%19.7%
Total Shareholders Equity i2.62B2.48B
Retained Earnings i2.44B2.37B
Retained Earnings % of Revenue i66.0%157.4%
Property, Plant & Equipment i458.28M411.30M

Cash Flow Statement Comparison

MetricKPL (2025)GUJTHEM (2025)
Operating Cash Flow i387.34M970.68M
Operating Cash Flow % of Revenue i10.5%64.4%
Capital Expenditures i-232.17M-1.16B
Free Cash Flow i277.15M-251.22M
FCF Margin i7.5%-16.7%
Debt Repayment i-133.57MN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricKPLGUJTHEM
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Shares Outstanding i10.38M108.97M
Float Shares i2.30M29.52M
% Held by Insiders i103.85%71.98%
% Held by Institutions i0.00%1.18%
% Held by Public i-3.85%26.84%

Dividend Analysis & Yield Comparison: Kwality Pharmaceuticals Ltd. vs Gujarat Themis Biosyn Ltd.

MetricKPLGUJTHEM
Last 12-Month Dividend i₹0.00₹0.67
Last 12-Month Dividend Yield iN/A0.17%
3-Year Avg Annual Dividend i₹0.00₹0.22
3-Year Avg Dividend Yield iN/A0.17%
3-Year Total Dividends i₹0.00₹0.67
Ex-Dividend DateN/ASep 04, 2025